Cargando…
Green biologics: The algal chloroplast as a platform for making biopharmaceuticals
Most commercial production of recombinant pharmaceutical proteins involves the use of mammalian cell lines, E. coli or yeast as the expression host. However, recent work has demonstrated the potential of eukaryotic microalgae as platforms for light-driven synthesis of such proteins. Expression in th...
Autores principales: | Taunt, Henry N., Stoffels, Laura, Purton, Saul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972929/ https://www.ncbi.nlm.nih.gov/pubmed/28892417 http://dx.doi.org/10.1080/21655979.2017.1377867 |
Ejemplares similares
-
The Algal Chloroplast as a Testbed for Synthetic Biology Designs Aimed at Radically Rewiring Plant Metabolism
por: Jackson, Harry O., et al.
Publicado: (2021) -
Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii
por: Stoffels, Laura, et al.
Publicado: (2017) -
Accelerating Chloroplast Engineering: A New System for Rapid Generation of Marker-Free Transplastomic Lines of Chlamydomonas reinhardtii
por: Taunt, Henry N., et al.
Publicado: (2023) -
Multigenic engineering of the chloroplast genome in the green alga Chlamydomonas reinhardtii
por: Larrea-Alvarez, Marco, et al.
Publicado: (2020) -
A PETase enzyme synthesised in the chloroplast of the microalga Chlamydomonas reinhardtii is active against post-consumer plastics
por: Di Rocco, Giulia, et al.
Publicado: (2023)